Ayman S. Sadek
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: August 11, 2026
Assessing cost-effectiveness in oncology treatment sequences: a review of pathway modeling methods for health technology assessment.
Journal: International journal of technology assessment in health care
Published: June 24, 2026
Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model.
Journal: Health technology assessment (Winchester, England)
Published: June 05, 2026
Mapping treatment effects on generic health-related quality of life scales from disease-specific measures using bivariate meta-analytic models and summary data.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: January 18, 2026
Network Meta-Analysis of Survival Outcomes With Non-Proportional Hazards Using Flexible M-Splines.
Journal: Statistics in medicine
Published: November 19, 2025
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal.
Journal: European journal of neurology
Published: August 01, 2025
Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model.
Journal: Health technology assessment (Winchester, England)
Published: September 13, 2024
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review.
Journal: Pharmacogenomics
Published: September 04, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026